Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandra P Belani

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Clinical Lung Cancer|November 5, 2003
Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapyChandra P Belani
Clinical Lung Cancer|January 15, 2004
Newer cytotoxic and targeted agents are advancing the treatment of lung cancerChandra P Belani
Clinical Lung Cancer|January 11, 2005
Emerging advances in the management of lung cancerChandra P Belani
Clinical Lung Cancer|August 18, 2004
Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Clinical Lung Cancer|December 10, 2003
Extensive-stage small-cell lung cancer: is the progress real?Chandra P Belani
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populationsChandra P Belani
Clinical Lung Cancer|November 12, 2003
Antinsense oligonucleotides in lung cancer: do they really make sense?Chandra P Belani
Clinical Lung Cancer|November 5, 2003
Elderly patients with advanced non-small-cell lung cancerChandra P Belani
Seminars in Oncology|August 10, 2002
Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancerChandra P Belani,
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Clinical Lung Cancer|November 5, 2003
Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapyChandra P Belani
Clinical Lung Cancer|January 15, 2004
Newer cytotoxic and targeted agents are advancing the treatment of lung cancerChandra P Belani
Clinical Lung Cancer|January 11, 2005
Emerging advances in the management of lung cancerChandra P Belani
Clinical Lung Cancer|August 18, 2004
Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Clinical Lung Cancer|December 10, 2003
Extensive-stage small-cell lung cancer: is the progress real?Chandra P Belani
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populationsChandra P Belani
Clinical Lung Cancer|November 12, 2003
Antinsense oligonucleotides in lung cancer: do they really make sense?Chandra P Belani
Clinical Lung Cancer|November 5, 2003
Elderly patients with advanced non-small-cell lung cancerChandra P Belani
Seminars in Oncology|August 10, 2002
Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancerChandra P Belani,
Pageof 21